NCT03120624 2026-02-04
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
Mayo Clinic
Phase 1 Active not recruiting
Mayo Clinic
Pfizer
Black Diamond Therapeutics, Inc.
Washington University School of Medicine
Eisai Inc.
Merrimack Pharmaceuticals